# Kaysersberg Pharmaceuticals SAS - Inspection Records

Source: https://www.keypedia.com/companies/kaysersberg-pharmaceuticals-sas/4f0bba88-dadd-49db-8e17-08165e705377

> Inspection records and compliance data for Kaysersberg Pharmaceuticals SAS in Kaysersberg, None. Access full analysis and detailed observations.

---

## Details

- Name: Kaysersberg Pharmaceuticals SAS
- FEI Number: 3002806288
- City: Kaysersberg
- State: None
- Country Name: France
- Address Line 1: 23 avenue Georges Ferrenbach
- Zip Code: None
- Business Operations: FDF MANUFACTURE

## Related Documents

- [FDA Inspection 1268813 - Kaysersberg Pharmaceuticals SAS - 2024-05-17](https://www.keypedia.com/records/fda_inspections/kaysersberg-pharmaceuticals-sas/095ff042-df17-4d35-9ebc-789a3322bd1b) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 17, 2024
- [483 - Kaysersberg Pharmaceuticals SAS - 2023-07-07](https://www.keypedia.com/records/483/kaysersberg-pharmaceuticals-sas/7ea9666e-82c7-40b1-a9c0-03ebefaa7e8e) — source: FDA, date: July 7, 2023
- [FDA Inspection 1211467 - Kaysersberg Pharmaceuticals SAS - 2023-07-07](https://www.keypedia.com/records/fda_inspections/kaysersberg-pharmaceuticals-sas/62c64822-d91d-4b24-a2f5-63f126424340) — source: FDA, date: July 7, 2023
- [FDA Inspection 1123773 - Kaysersberg Pharmaceuticals SAS - 2019-02-01](https://www.keypedia.com/records/fda_inspections/kaysersberg-pharmaceuticals-sas/463eba5d-a350-4378-b395-506f5abe1fb0) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 1, 2019
- [483 - Kaysersberg Pharmaceuticals SAS - 2016-07-19](https://www.keypedia.com/records/483/kaysersberg-pharmaceuticals-sas/0c0bf131-b1c2-42bc-9baa-13273ff535d0) — source: FDA, date: July 19, 2016
- [FDA Inspection 981303 - Kaysersberg Pharmaceuticals SAS - 2016-07-19](https://www.keypedia.com/records/fda_inspections/kaysersberg-pharmaceuticals-sas/107d2a0c-87ae-4a0f-95a0-14a5eb7bcbc2) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 19, 2016
- [FDA Inspection 661210 - Kaysersberg Pharmaceuticals SAS - 2010-04-19](https://www.keypedia.com/records/fda_inspections/kaysersberg-pharmaceuticals-sas/f7143227-32c0-41db-a06d-939c313901db) — classification: No Action Indicated (NAI), source: FDA, date: April 19, 2010

## Related Companies

- [CareFusion 213, LLC](https://www.keypedia.com/companies/carefusion-213-llc/a1fedbce-120c-4b06-8def-c5a653db579a)
- [Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Huanghe Road Site)](https://www.keypedia.com/companies/jiangsu-hengrui-pharmaceuticals-co-ltd-huanghe-road-site/02eeb237-fdd8-40a0-b45c-d4d88f49eb6c)
- [ENDO Pharmaceuticals Solutions, Inc.](https://www.keypedia.com/companies/endo-pharmaceuticals-solutions-inc/73c5da1a-04ad-4b56-9fae-f0a1371df51f)
- [Mylan Laboratories Limited](https://www.keypedia.com/companies/mylan-laboratories-limited/977203cc-5cbe-49ea-9b42-0b797ade4b5e)
- [Patheon Italia S.p.A](https://www.keypedia.com/companies/patheon-italia-spa/31dc9e92-7b25-4af0-82b4-c57b3efafbcf)
- [Gland Chemical Private Limited](https://www.keypedia.com/companies/gland-chemical-private-limited/a9851b78-88de-4303-8a8b-7793507fdbde)
- [Baxter Healthcare Corporation](https://www.keypedia.com/companies/baxter-healthcare-corporation/738590ab-c241-4de1-aaec-722e154bfc45)
- [Teva Pharmaceutical Industries Ltd.](https://www.keypedia.com/companies/teva-pharmaceutical-industries-ltd/0efdd88c-78c1-478c-aa05-d43a1b90886f)
- [Avara Liscate Pharmaceutical Services SPA](https://www.keypedia.com/companies/avara-liscate-pharmaceutical-services-spa/2dee93ec-8dc9-420b-b20d-da7f8948cf04)
- [INNOXEL LIFESCIENCES PRIVATE LIMITED](https://www.keypedia.com/companies/innoxel-lifesciences-private-limited/0dc5686b-60b1-4548-b527-0e81ccf7e674)

## Related Officers

- [Investigator](https://www.keypedia.com/people/michael-a-charles/f83241f0-ae3b-4535-ac03-e790bbf666ca)
- [Lori B. Wikstrom](https://www.keypedia.com/people/lori-b-wikstrom/19d938f7-4a5d-42b9-b2d1-e92cdb63bb0d)